MetaCap

Nektar Therapeutics Insider Trades

NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

41.17+0.37 (+0.91%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
16 · $2.43M
Shares bought / sold
0 / 40.93K
Net activity
Net selling $2.4 million

Nektar Therapeutics insider activity

Over the last 12 months, Nektar Therapeutics insiders reported 26 transactions on SEC Form 4: 0 open-market purchases and 16 sales. Insiders bought $0 and sold $2.4 million worth of stock, for net insider selling of $2.4 million. The largest seller was ROBIN HOWARD W, with $1.4 million in reported sales.

The most recent filing shows CHESS ROBERT (Director) reporting a transaction in 2,000 shares on Sep 23, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NKTR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NKTR insider transactions

Nektar Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 23, 2026Ajer Jeffrey RobertDirectorAward2,000—Form 4
Sep 23, 2026GREER R SCOTTDirectorAward2,000—Form 4
Sep 23, 2026WHITFIELD ROY ADirectorAward2,000—Form 4
Sep 23, 2026Brainard DianaDirectorAward2,000—Form 4
Sep 23, 2026CHESS ROBERTDirectorAward2,000—Form 4
Aug 18, 2026Zalevsky JonathanChief R&D OfficerSale186$13.39KForm 4
Aug 18, 2026ROBIN HOWARD WPresident & CEOSale418$30.09KForm 4
Jun 30, 2026Zalevsky JonathanChief R&D OfficerSale5,681$397.67KForm 4
Jun 17, 2026ROBIN HOWARD WPresident & CEOSale4,500$277.43KForm 4
Jun 17, 2026ROBIN HOWARD WPresident & CEOSale5,500$334.45KForm 4
Jun 16, 2026ROBIN HOWARD WPresident & CEOSale4,697$285.15KForm 4
Jun 16, 2026ROBIN HOWARD WPresident & CEOSale5,303$318.02KForm 4
Jun 15, 2026Zalevsky JonathanChief R&D OfficerSale5,538$336.21KForm 4
May 19, 2026ROBIN HOWARD WPresident & CEOSale444$29.09KForm 4
May 19, 2026Zalevsky JonathanChief R&D OfficerSale199$13.04KForm 4
Feb 18, 2026ROBIN HOWARD WPresident & CEOSale423$30.88KForm 4
Feb 18, 2026Zalevsky JonathanChief R&D OfficerSale180$13.14KForm 4
Jan 20, 2026Zalevsky JonathanChief R&D OfficerSale3,867$137.94KForm 4
Dec 22, 2025Zalevsky JonathanChief R&D OfficerAward6,250—Form 4
Dec 22, 2025ROBIN HOWARD WPresident & CEOAward21,667—Form 4
Nov 25, 2025ROBIN HOWARD WPresident & CEOSale2,207$119.80KForm 4
Nov 25, 2025Wilson Mark AndrewChief Legal OfficerSale630$34.20KForm 4
Nov 25, 2025Zalevsky JonathanChief R&D OfficerSale1,157$62.80KForm 4
Nov 21, 2025ROBIN HOWARD WPresident & CEOAward7,110—Form 4
Nov 21, 2025Wilson Mark AndrewChief Legal OfficerAward1,903—Form 4
Nov 21, 2025Zalevsky JonathanChief R&D OfficerAward2,666—Form 4
Sep 9, 2025ROBIN HOWARD WPresident & CEOSale1,210$58.30KForm 4
Sep 9, 2025ROBIN HOWARD WPresident & CEOSale2,156$102.39KForm 4
Sep 9, 2025ROBIN HOWARD WPresident & CEOSale1,200$55.69KForm 4
Sep 9, 2025ROBIN HOWARD WPresident & CEOSale2,100$94.84KForm 4
Sep 5, 2025ROBIN HOWARD WPresident & CEOSale1,136$45.32KForm 4
Sep 5, 2025ROBIN HOWARD WPresident & CEOSale2,226$86.41KForm 4
Sep 5, 2025ROBIN HOWARD WPresident & CEOSale3,304$125.12KForm 4
Sep 4, 2025Zalevsky JonathanChief R&D OfficerSale307$10.96KForm 4
Sep 4, 2025Zalevsky JonathanChief R&D OfficerSale189$6.50KForm 4
Sep 4, 2025Zalevsky JonathanChief R&D OfficerSale432$14.52KForm 4
Sep 4, 2025Zalevsky JonathanChief R&D OfficerSale793$25.72KForm 4
Sep 4, 2025ROBIN HOWARD WPresident & CEOSale1,134$40.60KForm 4
Sep 4, 2025ROBIN HOWARD WPresident & CEOSale613$21.09KForm 4
Sep 4, 2025ROBIN HOWARD WPresident & CEOSale1,496$50.18KForm 4
Sep 4, 2025ROBIN HOWARD WPresident & CEOSale1,923$62.25KForm 4
Sep 2, 2025ROBIN HOWARD WPresident & CEOSale1,500$45.24KForm 4
Sep 2, 2025Zalevsky JonathanChief R&D OfficerSale485$14.60KForm 4
Aug 19, 2025ROBIN HOWARD WPresident & CEOSale1,573$41.83KForm 4
Aug 19, 2025Wilson Mark AndrewChief Legal OfficerSale676$17.97KForm 4
Aug 19, 2025Zalevsky JonathanChief R&D OfficerSale725$19.28KForm 4
May 19, 2025ROBIN HOWARD WPresident & CEOSale23,208$15.55KForm 4
May 19, 2025Wilson Mark AndrewChief Legal OfficerSale9,996$6.70KForm 4
May 19, 2025Zalevsky JonathanChief R&D OfficerSale10,712$7.18KForm 4
Feb 19, 2025Wilson Mark AndrewChief Legal OfficerSale11,040$11.15KForm 4
Feb 19, 2025Zalevsky JonathanChief R&D OfficerSale10,300$10.40KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related